U.S., Dec. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07256600) titled 'PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers' on Nov. 20.
Brief Summary: A bioequivalence study comparing DWJ1445 and DWC202506 in healthy adults
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Subjects
Intervention:
DRUG: DWJ1445
1 tablet, Orally
DRUG: DWC202506
1 tablet, Orally
Recruitment Status: RECRUITING
Sponsor: Daewoong Pharmaceutical Co. LTD.
Published by HT Digital Content Services with permission from Health Daily Digest....